Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Version history
  • Article usage
  • Citations to this article

Advertisement

Research Article Free access | 10.1172/JCI105578

Basal Plasma Glucagon Levels of Man

Joseph E. Sokal and Ediz Z. Ezdinli

Department of Medicine, Roswell Park Memorial Institute, New York State Department of Health, Buffalo, N. Y.

†

Address requests for reprints to Dr. Joseph E. Sokal, Roswell Park Memorial Institute, Buffalo, N. Y. 14203.

*

Submitted for publication October 13, 1966; accepted January 17, 1967.

Supported in part by grant A-1646 from the National Institute for Arthritis and Metabolic Diseases.

Find articles by Sokal, J. in: PubMed | Google Scholar

Department of Medicine, Roswell Park Memorial Institute, New York State Department of Health, Buffalo, N. Y.

†

Address requests for reprints to Dr. Joseph E. Sokal, Roswell Park Memorial Institute, Buffalo, N. Y. 14203.

*

Submitted for publication October 13, 1966; accepted January 17, 1967.

Supported in part by grant A-1646 from the National Institute for Arthritis and Metabolic Diseases.

Find articles by Ezdinli, E. in: PubMed | Google Scholar

Published May 1, 1967 - More info

Published in Volume 46, Issue 5 on May 1, 1967
J Clin Invest. 1967;46(5):778–785. https://doi.org/10.1172/JCI105578.
© 1967 The American Society for Clinical Investigation
Published May 1, 1967 - Version history
View PDF
Abstract

The isolated perfused rat liver can serve as a bioassay system for glucagon, capable of detecting 10 mμg of this agent. Seven 15-ml plasma specimens obtained from different healthy volunteers after an overnight fast were assayed in this system; glucagon could not be detected in any of them, indicating concentrations significantly below 0.67 mμg per ml in all subjects. The effects of administering small doses of glucagon to patients were consistent with these results; imposition of increments to plasma glucagon concentration below 1 mμg per ml induced distinct and sustained increases in blood glucose.

Observations of the biologic effects of glucagon, together with data on the rate of its inactivation by the liver, suggest that the basal concentration of this hormone in peripheral plasma probably does not exceed 0.1 mμg per ml.

Browse pages

Click on an image below to see the page. View PDF of the complete article

icon of scanned page 778
page 778
icon of scanned page 779
page 779
icon of scanned page 780
page 780
icon of scanned page 781
page 781
icon of scanned page 782
page 782
icon of scanned page 783
page 783
icon of scanned page 784
page 784
icon of scanned page 785
page 785
Version history
  • Version 1 (May 1, 1967): No description

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Version history
Advertisement
Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts